Move comes in the wake of repeated slamming by the SC and the Parliamentary committee on health and family welfare
The government is considering framing a separate policy for the approval of medicines, as well as clinical trials conducted in India - in a move that is expected to strengthen regulation on the pharmaceutical industry and ensure patient safety in the country. The Union Ministry of Health and Family Welfare has constituted a committee, headed by Ranjit Roy Chaudhury, advisor in the health ministry, to formulate a policy "for approval of new drugs, clinical trials and banning of drugs".
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/policy-soon-drug-approval-clinical-trials
[2] http://admin.indiaenvironmentportal.org.in/category/author/sushmi-dey
[3] http://admin.indiaenvironmentportal.org.in/category/newspaper/business-standard-new-delhi
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/india
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drug-industry
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/medical-research
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/supreme-court
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health-effects
[10] http://admin.indiaenvironmentportal.org.in/category/thesaurus/ministry-health-and-family-welfare
[11] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health
